Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average) (2009 - 2026)

Idexx Laboratories' Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $79.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 2.05% year-over-year to $79.6 million; the TTM figure through Mar 2026 stood at $79.6 million (down 2.05% YoY), while the FY2025 annual figure was $80.4 million, down 2.47% from the prior year.
• Shares Outstanding (Weighted Average) was $79.6 million for Q1 2026 at Idexx Laboratories, down from $80.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $84.4 million in Q1 2022 to a low of $79.6 million in Q1 2026.
• Historically, Shares Outstanding (Weighted Average) has averaged $82.4 million across 5 years, with a median of $83.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) increased 0.13% in 2024, then retreated 3.12% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $83.6 million in 2022, then dropped by 0.67% to $83.1 million in 2023, then fell by 0.72% to $82.5 million in 2024, then decreased by 2.47% to $80.4 million in 2025, then fell by 0.97% to $79.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $79.6 million (Q1 2026), $80.4 million (Q4 2025), and $80.1 million (Q3 2025), per Business Quant data.